1181/1816US=8-A / Dermatologia
Tschachler E, Reitz Junior MS, Franchini G. Human retroviral disease: human T-lymphotropic viruses. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 2131-7. ISBN 978-0-07-138076-0.

DOENCA RETROVIRAL HUMANA; VIRUS LINFOTROPICO DA CELULA HUMANA; HTLV

1182/1816US=90 / Biol/Mol
Burgess AW, Garrett TPJ. EGFR signaling networks: EGF receptor family extracellular domain structures and functions. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 3-14. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

ERBB2; ERBB3; ERBB4; 3-DIMENSIONAL ESTRUTURAS; TRANSICOES CONFORMACIONAIS; EPITOPOS DE ANTICORPOS

1183/1816US=90 / Biol/Mol
Stern HM. EGFR signaling networks: EGFR family heteroimers in cancer pathogenesis and treatment. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 15-30. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

EGFR; ERBB1; HER2; ERB2; DIMEROS; CANCER; SINALIZACAO

1184/1816US=90 / Biol/Mol
Eigenbrot C. EGFR signaling networks: structure-function of EGFR kinase domain and its inhibitors. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 31-45. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

CRISTALOGRAFIA DE RAIOS X; INIBIDOR DE MOLECULA PEQUENA; ESCAPAR MUTACAO; ACTIVACAO DA CINASE; ALLOSTERY; L858R; T790M

1185/1816US=90 / Biol/Mol
Sorkin A. EGFR signaling networks: internalization and degradation of the EGF receptor. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 47-61. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

EGF; RECEPTOR; ENDOCITOSE; CLATRINA; UBIQUITINACAO; DEGRADACAO; ENDOSSOMO; LISOSSOMA

1186/1816US=90 / Biol/Mol
Xu W, Neckers L. EGFR signaling networks: differential dependence of EGFR and ErbB2 on the molecular chaperone Hsp90. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 63-71. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

CHAPERONES MOLECULARES; PROTEINA DE CHOQUE TERMICO 90; ANSAMICINAS BENZOQUINONA; GELDANAMICINA; HSP90 INIBIDOR; MUTACOES DE EGFR; SENSIBILIDADE AO FARMACO

1187/1816US=90 / Biol/Mol
Koppikar P, Grandis JR. EGFR signaling networks: activation of STATs 3 and 5 through the EGFR signaling axis. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 73-87. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

EGFR; STAT3; STAT5; STAT1; SCCHN; TRASNDUCAO DE SINAL

1188/1816US=90 / Biol/Mol
Wislez M, Kurie JM. EGFR signaling networks: the intersection of EGFR and the Ras signaling pathway. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 89-95. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

CANCER DE PULMAO; RAS; LIGANTES

1189/1816US=90 / Biol/Mol
Domin J. EGFR signaling networks: phosphoinositide 3-kanase enzymes as downstrem targets of the EGF receptor. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 97-117. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

AKT; FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR; QUINASE; FOSFATIDILINOSITOL; TRANSDUCAO DE SINAL; CELULA; CANCER; MITOGENESE; APOPTOSE; ENDOCITOSE

1190/1816US=90 / Biol/Mol
Pritchard JE, Jablonski AB, Parsons SJ. EGFR signaling networks: convergence of EGF receptor and Src family signaling networks in cancer. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 119-37. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

RECEPTOR DE EGF; EGFR; C-SRC

1191/1816US=90 / Biol/Mol
Gavard J, Gutkind JS. EGFR signaling networks: a molecular crosstalk between e-cadlherin and EGFR signaling networks. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 139-54. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

EGFR; JUNCOES CELULARES; ADESAO CELULAR; CADERINA; CATENINA MIGRACAO; ACTINA

1192/1816US=90 / Biol/Mol
Becker MA, Yee D. EGFR signaling networks: crosstalk between insulin-like growth factor (IGF) and epidermal growth factor (EGF) receptors. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 155-68. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

EGFR; IGF-IR; CANCER; MSPK; PI3K; CROSSTALK

1193/1816US=90 / Biol/Mol
Carraway KL, Yen L, Ingalla E, Sweeney C. EGFR signaling networks: negative regulation of signaling by the EGFR family. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 169-86. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

RECEPTOR EGF; CANCER DE MAMA; ERBB2; REGULADOR NEGATIVO; UBIQUITINA LIGASE E3; CAMUNDONGOS TRANSGENICOS

1194/1816US=90 / Biol/Mol
Lao HJ, Carpenter G. EGFR signaling networks: nuclear ErbB receptors: pathways and functions. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 187-97. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

ERBB; FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; NUCLEO; SINALIZAR; TRANSDUCAO

1195/1816US=90 / Biol/Mol
Blagoev B, Kratchmarova I, Olsen JV, Mann M. EGFR signaling networks: temporal dynamics of EGF receptor signaling by quantitative proteomics. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 199-207. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; NUCLEO; SINALIZAR; TRANSDUCAO

1196/1816US=90 / Biol/Mol
Johnson CG, McIntyre E, Gullick W. EGFR signaling networks: computational and mathematical modeling of the EGF receptor system. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 209-18. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

EGF RECEPTOR; MODELOS DE MATEMATICA; MODELOS DE PROGRAMAS

1197/1816US=90 / Biol/Mol
Normanno N, Bianco C, De Luca A, Strizzi L, Gallo M, Mancino M, Salomon DS. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: expression and prognostic significance of the EGFR in solid tumors. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 221-34. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

EGFR; ERBB2; ERBB3; ERBB4; EGF-COMO FATOR DE CRESCIMENTO; CANCER; PROGNOSTICO

1198/1816US=90 / Biol/Mol
Bennett HL, Brummer T, Timpson P, Patterson KI, Daly RJ. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: signaling by the EGF receptor in human cancers: accentuate the positive, eliminate the negative. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 235-55. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

SRC; RAS; RAF; ERK; PI3-QUINASE; PTEN; EGFR INIBIDORES; LOOPS DE FEEDBACK; C-CBL; ENDOCITOSE

1199/1816US=90 / Biol/Mol
Box C, Peak J, Rogers S, Eccles S. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: EGFR signaling in invasion, angiogenesis and metastasis. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 257-76. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

INVASAO; ADESAO; MOTILIDADE; PROTEOLISE; ANGIOGENESE; LINFANGIOGENESE; METASTASE

1200/1816US=90 / Biol/Mol
Wikstrand CJ, Bigner DD. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: constitutive activation of truncated EGF receptors in glioblastoma. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 277-92. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

AMPLIFICACAO DO GENE; IMUNOTERAPIA; MUTACAO; NEOPLASIAS DO SISTEMA NERVOSO; TRANSDUCAO DE SINAL

Primeira | Anterior | Próxima | Última